Get the Stockscreener App
0.00
100.00%
-6.81
Portage Biotech Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
See More
Previous Close:
$6.81
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$15.86M
Revenue:
-
Net Income/Loss:
$-67.28M
P/E Ratio:
0.00
EPS:
-94.66
Net Cash Flow:
$-9.80M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$15.82
Portage Biotech Inc Stock (PRTG) Company Profile
Compare PRTG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRTG
Portage Biotech Inc
|
0.00 | 15.86M | 0 | -67.28M | -9.80M | -94.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.71 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
696.27 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.42 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.46 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
367.81 | 41.77B | 4.56B | -176.77M | 225.30M | -1.7177 |
Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Mar-07-22 | Initiated | H.C. Wainwright | Buy |
| Sep-21-21 | Initiated | Oppenheimer | Outperform |
| Sep-02-21 | Initiated | B. Riley Securities | Buy |
| Aug-19-21 | Initiated | Cantor Fitzgerald | Overweight |
Portage Biotech Inc Stock (PRTG) Latest News
Published on: 2025-11-13 11:42:37 - newser.com
AlphaTON Capital and SingularityNET Join Forces to Accelerate Telegram’s Cocoon AI – Growing the Ethical, Decentralized AI Ecosystem - markets.businessinsider.com
How sentiment analysis helps forecast Portage Biotech Inc.July 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-11-12 21:03:13 - newser.com
Published on: 2025-11-12 17:45:39 - newser.com
Analyzing Portage Biotech Inc. with multi timeframe charts2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com
Using R and stats models for Portage Biotech Inc. forecastingRisk Management & Weekly High Conviction Ideas - newser.com
Applying chart zones and confluence areas to Portage Biotech Inc.2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Regression analysis insights on Portage Biotech Inc. performanceWeekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De’Ath as Chief Partnership Officer - markets.businessinsider.com
Published on: 2025-11-11 02:46:24 - newser.com
Published on: 2025-11-11 02:16:53 - newser.com
Is a relief rally coming for Portage Biotech Inc. holdersPortfolio Profit Report & Precise Trade Entry Recommendations - newser.com
How to integrate Portage Biotech Inc. into portfolio analysis tools2025 Top Gainers & Safe Entry Momentum Tips - newser.com
Published on: 2025-11-10 07:35:32 - newser.com
Published on: 2025-11-10 05:05:20 - newser.com
Published on: 2025-11-10 04:52:32 - newser.com
How Portage Biotech Inc. stock benefits from tech adoptionJuly 2025 Closing Moves & Consistent Income Trade Ideas - newser.com
Is Portage Biotech Inc. stock entering bullish territoryJuly 2025 Drop Watch & Capital Protection Trading Alerts - newser.com
Leading vs lagging indicators on Portage Biotech Inc. performanceQuarterly Growth Report & Technical Buy Zone Confirmations - newser.com
Is this a good reentry point in Portage Biotech Inc.Market Risk Summary & Safe Capital Growth Trade Ideas - newser.com
Is Portage Biotech Inc. stock a dividend growth opportunityTrade Ideas & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-09 12:21:48 - newser.com
Published on: 2025-11-09 03:59:35 - newser.com
Published on: 2025-11-09 03:35:28 - newser.com
Published on: 2025-11-08 06:01:29 - newser.com
Momentum divergence signals in Portage Biotech Inc. chartSwing Trade & Reliable Trade Execution Plans - newser.com
Using data tools to time your Portage Biotech Inc. exitBuy Signal & Growth Oriented Trade Recommendations - newser.com
What’s next for Portage Biotech Inc. stock priceEarnings Risk Report & Safe Swing Trade Setup Alerts - newser.com
Will Portage Biotech Inc. stock benefit from sector rotationQuarterly Profit Summary & Low Risk Growth Stock Ideas - fcp.pa.gov.br
Is Portage Biotech Inc. stock a defensive play in 2025Quarterly Portfolio Review & Daily Growth Stock Tips - Fundação Cultural do Pará
Published on: 2025-11-05 05:35:17 - newser.com
AlphaTON Capital to Acquire Premier Crypto Newswire Blockchain Wire, Cementing Dominance in Digital Asset Communications via the Telegram Ecosystem - markets.businessinsider.com
Published on: 2025-11-05 04:11:43 - newser.com
Portage Biotech Inc Stock (PRTG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.16%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):